New bifunctional Prodrugs with cleavable linker for targeted tumor therapy (ADC)
Scientists at the University of Göttingen in Germany developed new and highly potent drugs with cleavable chemical linkers to develop tumor specific antibodies for selective tumor therapy (ADC). The soluble prodrugs are activated into highly cytotoxic drugs only in targeted tumor cells.
Further information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A blueprint for mapping melting ice sheets
Researchers in the Stanford Radio Glaciology lab use radio waves to understand rapidly changing ice sheets and their contributions to global sea-level rise. This technique has revealed groundwater beneath Greenland,…
Water hyacinth plant pots – utilization of an invasive species
Together with Fiber Engineering GmbH, the DITF presents a process for the production of biodegradable plant pots. The products are cost effective and competitive. At the same time, the production…
Current research on the new 6G mobile communications standard
Nursing care robots, autonomous driving, digital twins: all of these high-tech applications will play an essential role for the new 6G mobile communications standard. The first commercial 6G networks are…